%e4%b8%ad%e5%8c%bb%e8%8d%af%e9%98%b2%e6%b2%bb%e4%bc%a0%e6%9f%93%e7%97%85%e7%9a%84%e7%9b%b8%e5%85%b3%e6%94%bf%e7%ad%96%e6%b3%95%e8%a7%84%e6%8e%a2%e6%9e%90...
DESCRIPTION
中医药防治传染病的相关政策法规探析TRANSCRIPT
-
20153373 Int J Trad Chin Med, March 2015, Vol. 37, No.3 193
WHO 10 Research on the related policies and regulations of Chinese medicine prevention and cure for infectious diseases Su Rui*, Han Jingdan, Fan Jiping. *TCM Development Center, China Academy of Chinese Medical Sciences, Beijing 100700, China Corresponding author: Fan Jiping, China Academy of Chinese Medical Sciences, 100700 Beijing, China; Email: [email protected]
Abstract The fast transmission and large range of emergence of infectious diseases jeopardize human health, social and economic development, which is a great threat to global public health. World Health Organization for the new features of infectious diseases on the International Health Regulations was revised to help member countries improve the ability to respond to public emergencies. Our government promptly revised the Communicable Disease Prevention Act, enacted a series of laws and strategies to promote the establishment of infectious disease surveillance and response systems. Chinese medicine was included in the country infectious disease prevention and control system. After nearly 10 years of development, the prevention and treatment of Chinese medicine on emergence of infectious diseases, the clinical medicine and research capacity of respond infectious diseases has been significantly improved, and become an important part of our system of infectious disease prevention and control.
Key words Emergence of infectious diseases; Chinese medicine; World Health Organization; Policies and regulations
Emergence of infectious diseases1
DOI: 10.3760/cma.j.issn.1673-4246.2015.03.001
2012ZX10004301200907001-9 100700 Email: [email protected]
2003 SARSWHO
1 2007 WHO 21
-
194 20153373 Int J Trad Chin Med, March 2015, Vol. 37, No.3
20 70 1 402WHO 20052007 3 1 2011 WHO 42010 1 2011 WHO () 354 820 23 826 496 114 449 5 772 224 589 854 10 426 21 050 223 338 76 022 1 350 639 2 296 1 844 9 943 4 088 65 549 953 275 24 1 625
2 2003 SARS 2003 5 2004 1989 SARS 37
2004 NIDRIS2006 2007 20052012 2003 WHO
3 1989 2004 52009
-
20153373 Int J Trad Chin Med, March 2015, Vol. 37, No.3 195
200911 41
4 2003 SARS 2008 6 2009 1.03
H1N1 782009 H1N1 H1N1 92010 41 10 35 2013 H7N9 H7N9
-
196 20153373 Int J Trad Chin Med, March 2015, Vol. 37, No.3
5 WHO WHO 10
1 Racaniello VR. Emerging infectious diseases[J]. J Clin
Invest,2004, 113(6):796-798. 2 WHO. The world health report 2007-A safer future: global public
health security in the 21st century[R]. Geneva:Wold Health Orgnization,2007.
3 WHO. International Health Regulations(2005)[EB/OL]. [2008-12-23]. http://www.who.int/ihr/publications/978924159 6664/en/.
4 WHO. World health statistics 2013[R]. Geneva:Wold Health Orgnization,2013.
5 . [EB/OL]. [2005-05-25]. http://www.gov.cn/banshi/2005-05/25/ content_971.htm.
6 . 4 [EB/OL].[2008-08-14]. http://www.moh.gov.cn/qjjys/ s8547/200808/3be5c5d8966a41b1a415b4211ec40795.shtml.
7 . [J]. -,2011,13(5):759-762.
8 . [N]. ,2011-07-13(3).
9 . [J]. ,2011,31(9):1168-1170.
2014-06-18
Oncibauerins A B 21213315U251UACC-62MCF-7NCI-ADR/RES786-0NCI-H460PC-3OVCAR-3HT29K562UACC-62K562GI506.83 g/ml0.5 g/ml
UACC-62GI500.01 g/ml111314GI5030 g/ml 1 OncibauerinA C26H30O145662Oncibauerin BC27H32O14580
[Phytochemistry Letters,2014,9:141-148]